| 0A4Y Stock | | | 0.23 0.01 4.55% |
Director
Jodie Pelz is Director Finance of AIM ImmunoTech
| Address | 2117 SW Highway 484, Ocala, FL, United States, 34473 |
| Phone | 352 448 7797 |
| Web | https://aimimmuno.com |
AIM ImmunoTech Management Efficiency
The company has return on total asset
(ROA) of
(0.8004) % which means that it has lost $0.8004 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(1.5479) %, meaning that it generated substantial loss on money invested by shareholders. AIM ImmunoTech's management efficiency ratios could be used to measure how well AIM ImmunoTech manages its routine affairs as well as how well it operates its assets and liabilities. At this time, AIM ImmunoTech's
Total Assets are comparatively stable compared to the past year.
Total Current Assets is likely to gain to about 60.6
M in 2024, whereas
Other Current Assets are likely to drop slightly above 611.2
K in 2024.
Similar Executives
AIM ImmunoTech (0A4Y) is traded on London Exchange in UK and employs 26 people. AIM ImmunoTech is listed under Oil, Gas & Consumable Fuels category by Fama And French industry classification.
Management Performance
AIM ImmunoTech Leadership Team
Elected by the shareholders, the AIM ImmunoTech's board of directors comprises two types of representatives: AIM ImmunoTech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AIM. The board's role is to monitor AIM ImmunoTech's management team and ensure that shareholders' interests are well served. AIM ImmunoTech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AIM ImmunoTech's outside directors are responsible for providing unbiased perspectives on the board's policies.
AIM Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AIM ImmunoTech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for AIM Stock Analysis
When running AIM ImmunoTech's price analysis, check to
measure AIM ImmunoTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AIM ImmunoTech is operating at the current time. Most of AIM ImmunoTech's value examination focuses on studying past and present price action to
predict the probability of AIM ImmunoTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AIM ImmunoTech's price. Additionally, you may evaluate how the addition of AIM ImmunoTech to your portfolios can decrease your overall portfolio volatility.